Back
Return
Biography
Prof. Don Mark Estes

Prof. Daniele Focosi

Azienda Ospedaliero-Universitaria Pisana, Italy

 

Email: dfocosi@tin.it

 

Qualifications

2006  M.D., University of Pisa, Italy

 

Publications (Selected)

  1. Focosi D, Galimberti S, Petrini M. Acute myeloid leukaemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases. Haematologica. 2007 Sep;92(9):e96-7
  2. Focosi D. Smoldering multiple myeloma. N Engl J Med. 2007 Sep 6;357(10):1048-9
  3. Focosi D, Caracciolo F, Galimberti S, Papineschi F, Petrini M. Long-term propylthiouracil use and acute myeloid leukaemia : a case report and review of the literature. Ann Hematol. 2008 Mar;87(3):233-5
  4. Focosi D, Kast RE, Petrini M. JC viremia and multiple sclerosis. J. Neurovirol. 2008 Jan;14(1):85-6
  5. Focosi D, Kast RE, Maggi F, Galimberti S, Ceccherini-Nelli L, Papineschi F, Petrini M. Central nervous system graft-versus host disease : consider progressive multifocal leukoencephalopathy among the differential diagnoses. Bone Marrow Transplant. 2007 Dec;40(11):1095-6
  6. Focosi D, Kast RE, Benedetti E, Papineschi F, Galimberti S, Petrini M. Phenobarbital-associated bone marrow aplasia: a case report and review of the literature. Acta Haematol. 2008;119(1):18-21
  7. Focosi D, Caracciolo F, Galimberti S, Papineschi F, Petrini M.. False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma. Ann Hematol. 2008 Apr;87(4):343-4
  8. Focosi D, Kast RE, Maggi F, Lauria G, Ceccherini-Nelli L, Petrini M. 5-HT(2a) inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease . J Infect Dis. 2008 Jan 15;197(2):328
  9. Focosi D, Cecconi N, Boni G, Orciuolo E, Galimberti S, Petrini M. Acute myeloid leukaemia after treatment with 90Y-ibritumomab tiuxetan for follicular lymphoma. Haematol Oncol 2008. In press
  10. Focosi D. Treatment for elderly patients with multiple myeloma. Lancet. 2008 Mar 22;371(9617):983-4
  11. Focosi D, Kast RE, Galimberti S, Petrini M. Conditioning response to granulocyte colony-stimulating factor via the dipeptidyl peptidase IV-adenosine deaminase complex. J Leukoc Biol. 2008 84(2):331-7
  12. Focosi D, Kast RE, Metelli MR, Benedetti E, Galimberti S, Papineschi F, Petrini M. Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: A report in a case of delayed graft failure. Leuk Res. 2008 33(1):178-81
  13. Focosi D, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M. Sialic acid moieties and 5-HT(2a): two faces of the same receptor for JC virus ? J Clin Virol. 2008 43(1):132-133
  14. Focosi D, Benedetti E, Maggi F, Papineschi F, Galimberti S, Ceccherini-Nelli L, Petrini M. Preemptive valganciclovir for cytomegalovirus infection in hematological patients. Transpl Inf Dis 2008 10(5):375-376
  15. Focosi D. Smartphone utilities for infectious diseases specialists. Clin Infect Dis 2008 47(9):1234-5
  16. Focosi D, Azzarà A, Kast R, Carulli G, Petrini M. Lithium and hematology: established and proposed uses. J Leukoc Biol 2008 85(1):20-8
  17. Focosi D, Maggi F, Pistolesi D, Benedetti E, Papineschi F, Galimberti S, Ceccherini-Nelli L, Petrini M. Hyperbaric oxygen therapy in BKV-associated hemorrhagic cytitis refractory to intravenous and intravesical cidofovir : case report and review of the literature. Leuk Res. 2009 33(4):556-560
  18. Focosi D, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M. Lymphotropic polyomavirus and progressive multifocal leukoencephalopathy. J Clin Microbiol 2009;47(1):284
  19. Focosi D, Maggi F, Ceccherini-Nelli L, Marchi S, Petrini M. Progressive multifocal leukoencephalopathy in autoimmune disorders. Gut 2009;58(4):605
  20. Focosi D, Pelosini M, Palla P, Galimberti S, Caracciolo F, Benedetti E, et al. Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous hematopoietic stem cell transplantation: Clinical response after plasma exchange. Transpl Immunol 2009
  21. Focosi D, Sordi E, Papineschi F, Benedetti E, Galimberti S, Petrini M. Fatal ongoing human cytomegalovirus reactivation during high-dose melphalan and autologous stem cell transplantation. J Med Virol 2009;81(5):857-60
  22. Focosi D. Does contrast enhancement predict survival in progressive multifocal leukoencephalopathy? J Infect Dis 2009 199(9):1410-1
  23. Focosi D, Kast R, Maggi FC-N, L, Petrini M. JC virus DNA in healthy brain tissue: A challenge for progressive multifocal leukoencephalopathy diagnosis. Ann Neurol 2009 65(2):230
  24. Focosi D, Maggi F, Andreoli E, Lanini L, Ceccherini-Nelli L, Petrini M. The role of bone marrow cells for JCV pathogenicity. J Clin Virol 2009 45(3):230-1
  25. Focosi D, Maggi F, Andreoli E, Lanini L, Ceccherini-Nelli L, Petrini M. Polyomaviruses other than JCV are not detected in progressive multifocal leukoencephalopathy. J Clin Virol 2009 45(2):161-2
  26. Focosi D. Bortezomib: the subtle line between drug-induced peripheral neuropathy and post-herpetic neuralgia. Clin Lymphoma Myeloma. 2009 Aug;9(4):E16-7
  27. Focosi D, Bestagno M, Burrone O, Petrini M. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol. 2010 Jan;87(1):107-16
  28. Focosi D, Maggi F, Albani M, Macera L, Ricci V, Gragnani S, Di Beo S, Ghimenti M, Antonelli G, Bendinelli M, Pistello M, Ceccherini-Nelli L, Petrini M. Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution. J Clin Virol. 2010 Feb;47(2):189-92